congratulations - great move! I didn't follow my own advice. I bought 2000 shares at $24 and said my short term target was $36. It hit $36 and I decided that ENTA was still undervalued. Bam. I can always congratulate a decent short.
Be careful shorting ENTA. Those selling today are overreacting to GILD's announcement this morning that they're going to push to get their drug on the market in Q1 '14. Although I realize that the first drug on the market will benefit from this, do you really think that ABBV (and thus, ENTA) will not get any market share? Really? If that's the case, why wouldn't ABBV just fold up tent and go home and award the entire market to GILD? ENTA has very little cash burn right now, they have $100 million in the bank, they're due another $155 million on/around June when ABBV gets FDA approval (the FDA has granted ABBV's drug "breakthrough" designation) and they're double digit royalties for years to come. This is not even factoring in Novartis' relationship with ENTA. People are just so short sighted anymore.